CD44 and cancer: Indeed, DCA is able to reduce cancer cell survival [155,156,157], and, in particular, in the aggressive and chemoresistant PC cell line PANC-1, low doses of DCA altered their energetic metabolism and caused diminished stemness by decreasing either the ratio between CD24+/CD44+/EPCAM+ cells and CD24+/CD44+ cells or by affecting spheroid integrity and survival [158].